Proteon sets IPO terms

Proteon Therapeutics Inc. (Waltham, Mass.) set a price range for its proposed IPO on NASDAQ. The company hopes to sell 4.7 million shares at $12-$14. At $13, Proteon would raise $61.1 million and be valued at $182.6 million. Stifel; JMP Securities; Baird and Oppenheimer & Co. are underwriters. Last month Proteon filed to raise up to $69 million. ...